Net profit of Hester Biosciences rose 8.01% to Rs 6.34 crore in the quarter ended June 2024 as against Rs 5.87 crore during the previous quarter ended June 2023. Sales declined 6.35% to Rs 82.27 crore in the quarter ended June 2024 as against Rs 87.85 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 82.27 | 87.85 | -6 |
| OPM % | 21.45 | 16.35 | - |
| PBDT | 14.73 | 14.31 | 3 |
| PBT | 10.59 | 8.91 | 19 |
| NP | 6.34 | 5.87 | 8 |